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1 Introduction
The need for prenatal diagnosis of fetal disease
in order to proceede to abortion or altered
delivery management has stimulated the devel-
opment of a range of techniques of fetal tissue
biopsy. More recently, in utero therapy of some
abnormalities has been possible such as direct
blood transfusion for anemia or drainage of
obstructed systems. Rapid improvements in ul-
trasound technology have not only increased
the safety and success of amniocentesis, fetos-
copy and placental biopsy but has also allowed
the development of direct ultrasound guided
techniques for fetal blood and tissue sampling.
Invasive procedures should only be performed
when the benefits of the knowledge obtained
outweigh the risks to the pregnancy. Such a
decision can only be made in consultation with
the parents and is affected by the prevailing
moral views, as well as the safety, effectiveness
and availability of the individual technique. In-
vasive procedures should only be performed
after a thorough ultrasound examination to
detect multiple pregnancy, fetal malformation
and placental localization and confirm fetal via-
bility and gestational age. Rhesus negative
mothers should be given anti-D Ig G.
Accurate assessments of complications are diffi-
cult since only high risk pregnancies are offered
invasive investigation. Spontaneous pregnancy
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problems are more common in this group and
are likely to be attributed to the invasive test.
Finding suitable control pregnancies is difficult
while randomizing such patients is almost
impossible.
In this article invasive methods of prenatal di-
agnosis and fetal therapy are discussed.
2 Techniques
2.1 Fetoscopy
Percutaneous, transabdominal, uterine endos-
copy allows both the diagnosis of serious struc-
tural abnormalities, too small to be detected
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ultrasonographically, and the visual guidance
of fetal tissue biopsy [20]. Fetoscopy is done
after 15 weeks' gestation; before this time the
size of the uterus and amniotic fluid volume
are too small for safe transabdominal entry.
The most appropriate gestation depends on the
procedure planned; for fetal examination orien-
tation is easier with the smaller fetuses and
clear amniotic fluid of 15 — 18 weeks, whereas
fetal blood sampling is usually performed from
18 weeks onwards. After 20 weeks the amniotic
fluid is cloudy but fetoscopy is possible until
late in the third trimester.
By detailed ultrasound examination a site of
entry can be identified which avoids damage to
the placenta, umbilical cord or fetus but allows
access to the fetal part being examined or biop-
sied. It is usually possible to find an area free
of placenta even when the latter is anterior.
Under sedation (which reduces fetal and ma-
ternal movements) and local anesthesia, a tro-
car and cannula (R. M. Surgical Developments,
Croydon) is inserted transabdorninally into the
amniotic cavity using a full aseptic technique.
A rigid fetoscope with fibre-optic illumination,
such as the Olympus Selfoscope, then replaces
the trocar (figure 1). It has a field of view of
55° and magnification, depending on distance
from the object of up to 30 times. If required,
a blood sampling needle or biopsy forceps can
be passed through the side channel of the can-
nula.
No major maternal complications have been
reported in over 6000 fetoscopies (8th Inter-
national Fetoscopy Meeting, 1985). The risks
to the fetus depend on operator experience; in
centers which have performed more than 100
fetoscopies the fetal mortality is less than 5%
and in the largest series it is about 2%. Morbid-
ity includes preterm labor (8 — 10%), amniotic
fluid leakage (10%) and amnionitis (0.5%).
Figure 1. Olympus Selfoscope, trocar and cannula (R.
M. Surgical Developments).
2.2 Ultrasound-guided procedures
Ultrasound allows the inspection of internal
anatomy. By scanning in each of the three di-
mensions the site of entry, direction and depth
required to reach an intended location can be
selected. When a needle is inserted its tip can
be identified by placing a real time curvi-linear
ultrasound-transducer parallel to it, allowing
the needle to be followed or guided (figures 2,
3). Some operators prefer sector or linear-array
scanners and we use either depending on the
uterine size.
There is less experience of ultrasound guided
biopsy than fetoscopy and its risks need further
evaluation but reports of ultrasound guided
cord blood sampling are very encouraging.
Invasive procedures to aid fetal imaging are be-
ing developed. The instillation of ultrasound
contrast media, such as physiological saline
solution, into the amniotic cavity in severe oli-
gohydramnios or into the fetal peritoneal cavity
for better definition of a renal abnormality may
be useful (unpublished observations).
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Figure 2. Ultrasound guided umbilical cord puncture for fetal blood sampling.
Figure 3. Ultrasound picture illustrating fetal blood sam-
pling from the umbilical cord at the placental insertion,
either fetoscopically or by ultrasound guided needling.
3 Prenatal diagnosis by fetal tissue biopsy
These techniques are restricted to patients at
high risk as indicated by family history, ad-
vanced maternal age, abnormal maternal serum
alpha-fetoprotein (MSAFP) or a structural ab-
normality detected by ultrasound scanning. A
new indication may be suspected intrauterine
hypoxia when estimation of fetal blood gas and
acid-base status [16, 27, 28] may help to time
the delivery.
The tissue that can give an accurate diagnosis
as quickly as possible is the one selected for
biopsy. This depends on the condition being
investigated and each tissue is now considered
in turn.
3.1 Amniotic fluid
Amniocentesis to diagnose inherited abnormal-
ities is done at about 16 weeks gestation because
the volume of amniotic fluid (150 — 200 ml) and
concentration of viable cells is sufficient and
the uterus is readily accessible transabdomi-
nally. The site of entry, direction and depth
required to enter a pocket of fluid while avoid-
ing fetal structures is identified. After antiseptic
skin cleaning, a needle, usually 21 gauge, with
or without a stillette, is inserted using a no-
touch technique. Once through the skin it can
be followed using real time ultrasound scanning
to allow correction of the needle direction, if
necessary, and to avoid a mobile fetus. The first
1 ml is discarded to avoid contamination with
maternal blood and then 15 —20ml is aspirat-
ed.
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Although amniocentesis is widely available its
disadvantage is that it is done after 15 weeks
and cytogenetic or enzymatic analysis requires
cell culture which in practice takes 3 — 4 weeks
resulting in much anxiety and a late termination
of pregnancy in the event of an abnormality.
Amniocentesis can also be performed later in
pregnancy to assess fetal lung maturity or the
severity of rhesus disease and to diagnose amni-
otic infection. In the past it was used for amni-
ography.
Three major collaborative studies on the risks
of amniocentesis have been published. Two with
a total of 2060 patients did not detect any
increased risk after amniocentesis compared
with matched controls or population data [13,
25]. One (2428 patients) found 1.7% more
spontaneous abortions or stillbirths in the am-
niocentesis group [12]. However, the control
group in the latter study had fewer pregnancy
complications than expected.
3.2 Placental (chorionic villus) biopsy
Ultrasound guided placental biopsy can be
done as early as 8 weeks gestation. Placenta
has fetal genetic material and cytogenetic or
DNA analysis potentially allows the diagnosis
of any fetal genetic disease at an early stage of
pregnancy. The rapid rate of cell division of
this tissue means cytogenetic preparations can
be made either directly [24] of following a short
period of culture which allows a faster and
earlier diagnosis than any other method. As the
membranes are not punctured this may be the
safest and quickest method of karyotyping at
any gestation [17]. Although both blind and
endoscopically guided placental biopsy have
been tried, greater success in obtaining tissue
with fewer complications has been found with
ultrasound guided biopsy, either transcervically
[30] or transabdominally [26].
A variety of instruments have been described
for transcervical biopsy including polyethelene
(Portex) or silver cannulae, biopsy forceps or
endoscopes but the principle of passing the
instrument through the cervix and into the pla-
centa with ultrasound guidance is the same. The
tissue obtained is examined microscopically and
chorionic villi are identified and separated from
decidual or blood contamination. For transab-
dominal placental biopsy a sector or curvi-lin-
ear scanner is used to direct a guide-needle
through the abdominal wall and uterus into the
placenta [26]. A finer biopsy needle is then
inserted through the guide needle and villi are
aspirated with a syringe. Repeated insertions of
the fine needle are possible if the sample is
inadequate. This technique is particularly suit-
able for later gestational ages when the cervix
is a long way from the placenta and it may also
have a lower risk of introducing infection than
transcervical biopsy. However experience with
this method is limited and it requires further
investigation.
The main short-term risk of this procedure is
that of miscarriage which occurs in 2 — 5% of
pregnancies. The "expected" miscarriage rate
for a control population has not yet been accu-
rately established. Whether there is an increase
in longer term sequelae e. g. IUGR, abruptio
placentae or malformation is not known either.
Small fetoplacental haemorrhages have been
detected by MSAFP assay in about 50% of
patients [31].
3.3 Blood
Fetal blood is valuable for the diagnosis of a
large number of disorders and can be used to
clarify equivocal results from other tissues, for
example when detailed banding is required or
after failure of, or mosaicism in, amniotic fluid
cell culture [21]. Vessels in the chorionic plate
(placentesis) or umbilical cord, or the fetal heart
can be punctured. The needle can be guided
either by fetoscopy [18] or by ultrasound [5].
Placentesis involves multiple punctures of the
chorionic plate to produce bleeding into the
amniotic fluid which is then aspirated and
checked for the presence of fetal cells. This
procedure has the risk of producing excessive
fetal bleeding and there is a 10% fetal mortality.
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Furthermore, contamination with amniotic
fluid or maternal blood may make diagnosis
difficult.
By fetoscopy the umbilical cord placental inser-
tion can be identified and the vessels seen
through the Whartons' jelly. This site has the
advantages that blood coming from a cord ves-
sel must be fetal and that hemostasis is excel-
lent. Pure fetal blood can be achieved in 100%
of patients but a particle size analyzer (Coulter
Channelyzer) should be available to provide
confirmation.
For ultrasound-guided needling of the cord, the
placental insertion is identified sonographically.
An entry site is chosen so that the needle ap-
proaches the cord nearly parallel to the in-
tended vessel. If the placenta is anterior, a trans-
placental route is easiest and does not puncture
the membranes. With a posterior placenta, a
transamniotic approach may be necessary and
is usually more difficult. Initial results are very
encouraging, with high success and low compli-
cation rates [6]. This technique is a quick, out-
patient procedure and has been used for ante-
partum diagnosis of fetal asphyxia by measur-
ing fetal blood gases in high risk pregnancy
[16, 27, 28]. Furthermore by sampling placental
lakes of maternal blood it has been possible to
study placental transfer [29].
The fetal heart has also been used as a source
of blood [1]. A 1.2 mm guide needle is directed
into the fetal thorax and a 0.6mm diameter
needle is passed down this into the left ventricle.
The technique does not appear to have harmful
effects on the fetal heart but it also needs fur-
ther evaluation.
3.4 Skin
Fetal skin is required for the prenatal diagnosis
of severe skin diseases that do not effect other
systems and cannot yet be identified at the gene
level. The fetoscope allows precise identifica-
tion of the area to be biopsied and selection of
the type of skin desired (e. g. a hairy area, such
as the scalp or eyebrows, for the diagnosis
of oculocutaneous albinism). The specimen is
immediately examined microscopically by an
experienced histologist to ensure adequacy of
the biopsy.
Biopsy forceps can be passed down the feto-
scope cannula after removal of the endoscope
and the biopsy guided by ultrasound. Special
skin biopsy instruments have also been devised
which are inserted transabdominally and
guided by ultrasound to the fetal skin. The
great advantage of ultrasound in being able
to "see" through tissues is not useful in this
procedure whereas the ability to see surfaces in
great detail makes fetoscopy espescially suc-
cessful.
3.5 Liver
Some rare enzyme deficiencies of the urea cycle
are expressed only in the liver eg. carbamyl
phosphate synthetase and ornithine carbamyl
transferase (OCT). They can be diagnosed pre-
natally using fetal liver [23], although a gene
probe is available for some cases of OCT defi-
ciency. By fetoscopy the right nipple and umbil-
icus are identified and a point half-way between
these is chosen. A needle is inserted subcostally
into the liver, strong suction is applied and the
needle withdrawn, obtaining a core of tissue.
Similarly an ultrasound guided method has
been described [9]. Ultrasound scanning allows
identification of the needle tip within the liver.
3.6 Urine
When an obstruction of the fetal urinary system
is detected by ultrasound examination, further
investigation should include an assessment of
residual renal function. A needle can be guided
by ultrasound into the fetal bladder and urine
aspirated for biochemical analysis. Further-
more after emptying the bladder the rate of re-
filling can be observed by serial ultrasound
examinations. This information helps decide
whether a vesico-amniotic shunt would be ben-
eficial.
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3.7 Tumors
Similar techniques to those for liver biopsy can
be used for fetal tumors. We have diagnosed
type 3 cystic adenomatoid malformation of the
lung by ultrasound guided fetal lung biopsy at
20 weeks' gestation.
4 Fetal therapy
When the diagnosis of a potentially reversible
or treatable fetal abnormality is made, the de-
livery should be in a specialist center. To pre-
vent further damage or fetal death in utero due
to a progressive lesion early delivery for surgery
or therapy may be indicated. If the fetus is too
premature for delivery in utero treatment may
be considered. This should only be undertaken
after exclusion of associated structural or
chromosomal abnormalities and after demon-
stration that the primary lesion or its secondary
effects are indeed progressive and that residual
function compatible with postnatal life remains.
Parents should be fully involved and warned of
range of possible outcomes.
4.1 Blood transfusion
Severe rhesus isoimmunization can cause fetal
anemia, hydrops fetalis and intrauterine death
before the fetus is capable of extrauterine sur-
vival. Ultrasound scanning to time, guide and
follow-up fetal transfusion and for monitoring
during and between transfusions has greatly
improved the prognosis of severely affected
fetuses and has replaced the original X-ray
techniques. Blood can be given into the fetal
peritoneal cavity (IPT) [10] or intravascularly
(IVT) [19]. A pure fetal blood sample is ob-
tained using the methods described earlier and
the fetal hemoglobin concentration and blood
group determined and a direct Coomb's test
performed. An empirical but safe estimate of
the volume of blood to be given intraper-
itoneally is [7];
(gestation in weeks — 20) χ 10ml
Recently the volume of blood required for IVT
has been calculated from previously obtained
data on the feto-placental blood volume [14]
and the donor and fetal hematocrits.
4.1.1 Intraperitoneal transfusion
Under sedation and local anesthesia a 16-gauge
Tuohy needle is inserted into the uterus so as
to allow access to the antero-lateral aspect of
the fetal abdomen. A linear-array, real-time
ultrasound transducer is aligned so as to iden-
tify the needle-tip and fetal abdomen. The
needle is inserted into the peritoneal cavity be-
tween the umbilicus and bladder and any ascites
aspirated. The needle position is confirmed by
a 4—5 ml injection of isotonic saline and then
packed adult blood, compatible with the
mothers', is injected through the needle at a
rate of 3 — 5 ml/min. IPT can also be performed
with combined fetoscopic and sonographic gu-
idance by passing a 21 gauge Tuohy needle
(R. M. Surgical Developments) down the side
arm of the fetoscope cannula. This may be
done, after a fetal blood sample has been taken,
when the amniotic fluid is very cloudy, in early
pregnancy (eg. < 20 weeks), or when a large
volume of blood is required, in combination
with IVT.
4.1.2 Intravascular transfusion
After fetal blood sampling with fetoscopic or
ultrasonic guidance (for hematocrit estimation
with a Coulter Channelyzer) the needle tip is
kept in the lumen of the vessel and donor blood
is injected at a rate of 1 — 3 ml/min, while ob-
serving the fetal heart continuously with ultra-
sound. The aim is to achieve a final fetal hema-
tocrit of 35 — 45% and this is checked by aspi-
rating a post-transfusion sample. There is much
greater experience of this technique by fetos-
copy [22]. Exchange transfusion has been per-
formed fetoscopically before mid-trimester
abortion [11] but the risk to continuing preg-
nancies seems to be greater than "top-up"
transfusion.
Alternative methods of IVT include ultras-
ound-guided puncture of the intrahepatic um-
bilical vein [2] or fetal heart. Experience with
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Ultrasound
= I transducer
Figure 4. Ultrasound guided intravenous fetal blood
transfusion in rhesus disease.
these methods however, is too small for accu-
rate assessment of efficiency and risks. We have
recently used an ultrasound-guided cord
puncture technique and infused blood through
the same needle after determination of the fetal
hematocrit (figure 4).
4.1.3 Albumin infusion
Fetuses with non-immune hydrops have very
low blood albumin concentrations [15] and it
has been suggested that the low oncotic pres-
sure increases the loss of fluid from the vascular
compartment. We have given albumin infusions
to several fetuses but the results need further
evaluation.
4.2 Drainage procedures
Obstruction of fetal systems can cause dilata-
tion and damage to both the primary organ
and the adjacent structures. By-passing the
obstruction and reducing the pressure may pre-
vent further damage until delivery when more
definitive surgery is possible. These procedures
are only helpful if there is no major untreatable
abnormality and if useful residual organ func-
tion remains.
4.2.1 Obstructive uropathy
Complete obstruction of the urinary system
from an early gestation leads to renal dysplasia
and absence of renal function. Incomplete or
late onset obstruction may allow good renal
development but still compromise renal func-
tion to a degree that depends on the duration
and completeness of obstruction. Renal paren-
chymal thickness and consistency, assessed ul-
trasonographycally, and urine biochemistry can
help to estimate residual renal function [21].
Experimental work suggested that relief of
obstruction in utero was beneficial [8] and sub-
sequently suprapubic insertion of a vesico-am-
niotic shunt was performed in several centers.
A cannula (Rocket of London) is guided into
the distended fetal bladder by ultrasound.
Through this, a double "pig-tail" catheter is
introduced so that one end curls up inside the
bladder and the other outside the fetal trunk
in the amniotic cavity. Urine is thus released,
amniotic fluid is formed, and the secondary
complications of both renal damage and oli-
gohydramnios can be reduced in some cases.
4.2.2 Obstructive hydrocephalus
High-pressure ventricular dilatation causes
brain damage. After delivery, ventricular shunt-
ing limits further structural damage and may
improve the prognosis. If prematurity prevents
delivery and there is sonographic evidence of
increasing ventriculomegaly, in utero drainage
could be beneficial.
Repeated ultrasound guided cerebro-spinal
fluid (CSF) aspiration (encephalocetesis) has
been attempted but ventricular dilatation still
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occured because of rapid reaccumulation [3].
Ventriculo-amniotic shunts, with a one-way
valve allowing CSF out of the brain, have been
inserted under ultrasound guidance [4]. Reduc-
tion in ventricular dilatation has been achieved
but follow-up developmental studies have been
discouraging (Fetal Surgery Registry 1986) and
major problems have been experienced in main-
taining shunt patency and position.
4.2.3 Pleural effusions
Fetal pleural effusions can occur as part of
generalised hydrops fetalis or as an isolated
abnormality (chylothorax) and prevent expan-
sion and development of the fetal lung. A
pleuro-amniotic shunt can be inserted with ul-
trasound guidance using similar equipment to
that described for bladder catheterization. We
have now treated four such fetuses in this man-
ner and in one, associated generalized hydrops
was reversed. Post-natal outcome in these ba-
bies has been excellent.
4.2.4 Cyst aspiration
Large fetal cysts occur as an isolated abnormal-
ity or as part of a syndrome (e. g. cystic hygro-
mata in Turner's syndrome). Pressure effects or
obstruction at delivery may be prevented by
needle puncture and aspiration.
4.3 Drug therapy
Fetal drug therapy such as digoxin in hydrops
fetalis or anti-arrhythmic agents for fetal car-
diac arrhythmias is usually administered across
the placenta through the mother [32]. Substan-
ces that are not adequately transferred may be
injected into the amniotic cavity or directly into
the fetal blood stream. For resuscitation of
previable fetuses with reversible causes of car-
diovascular collapse transplacental therapy is
too slow. We have successfully administered
adrenaline, calcium and atropine directly to
fetuses when cardiac arrest occured during an
invasive procedure such as blood transfusion
(unpublished).
Keywords: Fetal therapy, fetal tissue biopsy, fetoscopy, prenatal diagnosis, ultrasound guided needle biopsy.
Zusammenfassung
Invasive Techniken zur pränatalen Diagnose und Therapie
Bei der Fetoskopie wird ein Endoskop transabdominal in
die Amnionhöhle vorgeschoben und somit die Diagnose
kleiner struktureller Defekte sowie die Biopsie von feta-
lem Gewebe unter Sichtkontrolle ermöglicht. Mit Hilfe
des Ultraschalls wird der Zugang so gewählt, daß sich
das Endoskop an dem fetalen Abschnitt, der untersucht
oder biopsiert werden soll, befindet und eine Verletzung
der Plazenta, der Nabelschnur oder des Feten vermieden
wird.
Die Nadelbiopsie unter Ultraschallkontrolle wird heute
zur Gewinnung verschiedener fetaler Gewebe eingesetzt.
Die Nadel kann durch die gleichzeitige Untersuchung
mit einem Real-time-Ultraschalltransducer in den Gewe-
ben identifiziert und somit richtig geführt werden.
Pränatale Diagnose durch fetale Gewebeentnahme: Zur
Diagnose vererbter Erkrankungen wird um die 16.
Schwangerschaftswoche, nämlich dann, wenn die
Fruchtwassermenge und die Konzentration fetaler Zel-
len ausreichend sind und der Zugang zum Uterus mög-
lich ist, eine Amniozentese durchgeführt. Zunächst wer-
den die optimale Punktionsstelle, Richtung und Tiefe
zum Erreichen eines Fruchtwasserpools bestimmt und
dann eine 20 gauge-Nadel unter Ultraschallkontrolle
eingeführt. Der Nachteil dieser Methode ist, daß sie erst
nach der 15. Woche durchgeführt werden kann und für
die Diagnose Zellkulturen angelegt werden müssen, so
daß die Frauen sehr lange besorgt sind und im Falle
eines pathologischen Befundes die Schwangerschafts-
beendigung sehr spät erfolgt.
Die Chorionzottenbiopsie unter Ultraschallkontrolle
wird normalerweise frühestens in der 8. Schwanger-
schaftswoche durchgeführt. Bei der transzervikalen
Biopsie wurden verschiedene Kanülen, Biopsiezangen
und Endoskope eingesetzt. Prinzipiell gibt es jedoch
beim Einbringen des Instrumentes durch die Zervix in
die Plazenta unter Ultraschallkontrolle keine Unter-
schiede. Bei der transabdominalen Biopsie wird die Na-
del durch die Bauchwand und den Uterus in die Plazenta
eingeführt. Diese Methode eignet sich speziell für spätere
Schwangerschaftswochen und ist möglicherweise mit
einem geringeren Infektionsrisiko behaftet als die trans-
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zervikale Biopsie. Wir konnten kürzlich zeigen, daß zu
jedem Schwangerschaftsalter ein fetaler Karyotyp aus
Plazentagewebe erstellt werden kann.
Fetales Blut kann durch Punktion der Nabelschnur an
der plazentaren Insertionsstelle gewonnen werden. Der
Nabelschnuransatz kann fetoskopisch oder sonogra-
phisch identifiziert werden, und die Nadel wird in eines
der Gefäße eingeführt. Für die pränatale Diagnose eini-
ger schwerer Hauterkrankungen wird fetales Hautmate-
rial benötigt. Die Biopsiezange kann durch einen zweiten
Zugang am Fetoskop eingeführt werden. Einige seltene
Enzymdefekte des Harnstoffzyklus sind nur in Leberzel-
len nachweisbar. Infrakostal wird eine Nadel in die Leber
eingeführt und nach Absaugen Lebergewebe gewonnen.
Mit der gleichen Technik können fetale Tumoren biop-
siert und histologisch untersucht werden. Bei Feten mit
obstruktiven Harnwegserkrankungen kann eine Urin-
probe entnommen werden, um über die biochemische
Analyse die Nierenfunktion zu erfassen. Nach Entleeren
der Blase kann per Ultraschall die Auffüllung beobach-
tet werden. Dies stellt eine Entscheidungshilfe dar, ob
ein vesiko-amnialer Shunt günstig ist oder nicht.
Fetale Therapie: Zur intraperitonealen Transfusion (IPT)
wird eine 16 gauge-Tuohynadel unter Ultraschallkon-
trolle zunächst in den Uterus und dann in das fetale
Abdomen zwischen Nabel und Harnblase eingeführt.
Mit dem mütterlichen Blut kompatible Erythrozyten-
konzentrate von Erwachsenen werden mit einer Ge-
schwindigkeit von 3 — 5 ml/min infundiert. Die intravas-
kuläre Transfusion (IVT) wird so durchgeführt, daß nach
einer Blutabnahme unter fetoskopischer oder sonogra-
phischer Kontrolle die Nadelspitze im Gefaßlumen
bleibt und dann Spenderblut infundiert wird. Angestrebt
wird ein fetaler Hämatokrit von 35—45%. Bei Feten
mit nicht-immunologischem Hydrops haben wir bei sehr
niedrigen Albuminwerten im Plasma Albumin infun-
diert.
Drainagen: Für einige Feten mit obstruktiven Harnwegs-
erkrankungen ist eine Drainage in utero günstig. In der
überdehnten Blase wird unter Ultraschallkontrolle eine
Kanüle plaziert und dadurch ein doppelter „pig-tail" -
Katheter eingeführt, so daß sich ein Ende innerhalb der
Blase aufwickelt und das andere in der Amnionhöhle.
Der Urin kann abfließen, Fruchtwasser gebildet werden
und die sekundären Komplikationen sowohl einer rena-
len Schädigung wie auch eines Oligohydramnions kön-
nen in einigen Fällen reduziert werden. Bei Neugebore-
nen mit Hydrozephalus kann ein Ventrikelshunt die Hirn-
schädigung reduzieren. Wenn wegen Prämaturität eine
Entbindung nicht möglich ist, kann ein ventrikulo-am-
nialer Shunt mit einer one-way-Klappe, durch die der
Liquor abfließen kann, unter Ultraschallkontrolle einge-
setzt werden. Man kann so die Ventrikeldilatation ver-
mindern; die Ergebnisse von Nachuntersuchungen zur
Erfassung der körperlichen und geistigen Entwicklung
waren jedoch entmutigend. Pleuraergüsse behindern die
Ausdehnung und Entwicklung der fetalen Lunge. Pleu-
ro-amniale Shunts, die nach dem gleichen Prinzip wie die
oben beschriebene Blasenkatheterisierung funktionieren,
können hier eingesetzt werden. Große fetale Zysten kön-
nen abgesaugt werden, um Druckschäden oder auch
Geburtshindernisse zu vermeiden.
Medikamentöse Therapie: Wenn Medikamente nicht
oder zu langsam die Plazenta passieren, kann die direkte
Applikation an den Feten versucht werden. Wenn wäh-
rend eines invasiven Eingriffes ein kardiovaskulärer Kol-
laps auftrat, konnten wir stark deprimierte Feten durch
intravenöse oder intramuskuläre Gaben von Adrenalin,
Kalzium und Atropin erfolgreich reanimieren.
Schlüsselwörter: Fetale Gewebeentnahme, fetale Therapie, Fetoskopie, Nadelbiopsie unter Ultraschallkontrolle,
pränatale Diagnose.
Resume
Techniques invasives pour le diagnostic et la therapeutique
prenatales
La feotoscopie necessite l'insertion transabdominale d'un
endoscope dans la cavite amniotique. Elle pennet ä la
fois le diagnostic d'anomalies structurales minimes et la
realisation de biopsies tissulaires foetales sous le contröle
de la vue. On localise par echographie le site d'abord
permettant l'acces aux regions foetales ä examiner ou ä
biopsier, tout en evitant les lesions du placenta, du
cordon ombilical ou du foetus.
On a recemment etendu ä de nombreux tissus foetaux
les biopsies ä l'aiguille sous contröle echographique. On
peut visualiser une aiguille ä l'interieur des tissus en
plagant une sonde d'echographie en temps reel parallele-
ment a eile, ce qui permet de guider raiguille.
Diagnostic prenatal par biopsie de tissus foetaux: L'amnio-
centese a visee diagnostique des anomalies hereditaires
est effectuee a environ 16 semaines de gestation lorsque
le volume de liquide amniotique, la concentration cellu-
laire et l'accessibilite ä Futerus sont adequats. Sous
contröle echographique en temps reel on repere le point
de ponction, la direction et la profondeur necessaires
pour atteindre une poche de liquide amniotique et on
intraduit une aiguille de calibre 20. L'inconvenient de
cette technique est qu'elle est effectuee apres 15 semaines
et que l'analyse necessite en regle generate une culture
cellulaire ce qui entraine une anxiete prolongee et une
interruption tardive en cas d'anomalies.
La biopsie placentaire (villosites chorioniques) echo-gui-
dee est habituellement realisee dans la Seme semaine de
gestation. On a utilise bon nombre de canules, de pinces
ä biopsie et d'endoscopes pour ces biopsies placentaires
par voie transcervicale, mais le principe du passage des
instruments ä travers le col et ä l'interieur du placenta
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sous controle echographique est le meme. Pour la biopsie
placentaire transabdominale on introduit une aiguille ä
travers la poroi abdominale et Futerus dans le placenta.
Cette methode est particulierement adaptee pour les
ages gestationnels plus tardifs et eile presente un risque
moindre d'introduire une infection que par la voie tran-
scervicale. Nous avons recemment montre que peut
realiser le caryotype sur les tissus placentaires pour toute
grossesse.
Le sang foetal est obtenu par ponction du cordon ombili-
cal au niveau de son insertion placentaire. On peut
localiser l'insertion du cordon par foetoscopie ou par
echographie, et on introduit Paiguille dans un des vais-
seaux. Pour le diagnostic prenatal de certaines affections
cutanees graves il faut de la peau fetale. On peut faire
passer la pince ä biopsie dans le canal lateral du foetos-
cope. Certains deficits enzymatiques rares du cycle de
Furee ne s'expriment qu'au niveau hepatique. On intro-
duit une aiguille en sous-costal dans le foie et par aspira-
tion on obtient un fragment tissulaire.
Therapeutique fatale: Pour les transfusions intraperitonea-
les (IPT) on introduit dans Futerus puis dans 1'abdomen
foetal, entre Fombilic et la vessie, une aiguille de Tuohy de
calibre 16, sous controle echographique. On injecte du
sang adulte, compatible avec la mere, au rythme d'environ
3 ä 5 ml/min. Les transfusions intra-vasculaires sont reali-
sees apres prelevement de sang foetal par foetoscopie ou
sous controle echographique, Fextremite de Faiguille lais-
see en place dans la lumiere vasculaire, on injecte du sang
de donneur. Le but est d'obtenir ä la fin un hematocrite
foetal de 35—45%. Nous avons realise des perfusions d'al-
bumine chez des foetus presentant un hydrops non immu-
nologique, lorsque les concentrations d'albumine plasma-
tique etaient tres basses.
Techniques de drainage: Certains foetus presentant une
uropathie obstructive peuvent beneficier d'un drainage in
utero. On introduit dans la vessie distendue sous
controle echographique une canule ä travers laquelle on
fait passer un catheter double «queue de cochon» de
teile sorte que Fune des extremites forme une boucle ä
Finterieur de la vessie et Fautre en dehors du tronc foetal
dans la cavite amniotique. L'urine est liberee, le liquide
amniotique se forme, et les complications secondaires et
de la souffrance renale et de Foligoamnios peuvent etre
diminuees dans certains cas. Les shunts ventriculaires
neonataux pour hydrocephalie peuvent diminuer les le-
sions cerebrates, et lorsque la prematurite empeche Fac-
couchement on peut mettre en place sous controle
echographique un shunt ventriculo-amniotique ä Faide
d'une valve ä une voie, ce qui pennet Fissue du LCR en
dehors du cerveau. On obtient ainsi une reduction de
la dilatation ventriculaire, mais les etudes du suivi du
developpement ne sont pas encourageantes. Les epanche-
ments pleuraux interferent avec Fexpansion et le develop-
pement des poumons foetaux. On peut installer des
shunts pleuro-amniotiques en utilisant un materiel simi-
laire ä celui decrit pour le catheterisme vesical. On peut
aspirer les kystes foetaux volumineux pour eviter une
compression ou un obstacle lors de Faccouchement.
Traitements medicamenteux: On a essaye d'admimstrer
des medicaments directement au foetus quand ils ne
traversent pas le placenta de fagon adequate ou quand
le transfert est trop lent. Nous avons reanime avec succes
des foetus avant la viabilite ä Faide d'adrenaline, de
calcium et d'atropine en intraveineux ou en intra-muscu-
laire lorsque survient un collapsus cardio-vasculaire au
cours des techniques invasives.
Mots-cles: Biopsie ä Faiguille echo-guidee, biopsie de tissus foetaux, diagnostic prenatal, foetoscopie, therapeutique
foetale.
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